Successful use of miltefosine and sodium stibogluconate, in combination, for the treatment of an HIV-positive patient with visceral leishmaniasis: a case report and brief review of the literature.

Fernando Laguna, Rogelio López-Vélez, Federico Pulido, Ana Salas, Julián Torre-Cisneros, Enrique Torres, Francisco J Medrano, Jesús Sanz, Gabriela Picó, Javier Gómez-Rodrigo, Juan Pasquauk, Jorge Alvar, Spanish HIV-Leishmania Study Group, None, Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B AIDS. ,vol. 13, pp. 1063- 1069 ,(1999) , 10.1097/00002030-199906180-00009

Markus Rihl, Matthias Stoll, Kai Ulbricht, Franz-Christoph Bange, Reinhold-Ernst Schmidt, Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe Journal of Infection. ,vol. 53, pp. e25- e27 ,(2006) , 10.1016/J.JINF.2005.09.015

H. Sindermann, K. R. Engel, C. Fischer, W. Bommer, , Oral Miltefosine for Leishmaniasis in Immunocompromised Patients: Compassionate Use in 39 Patients with HIV Infection Clinical Infectious Diseases. ,vol. 39, pp. 1520- 1523 ,(2004) , 10.1086/425359

G. Angarano, P. Maggi, S. L. Coppola, R. L. Cavaliere, Itraconazole as maintenance therapy for visceral leishmaniasis in HIV-infected patients. European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 17, pp. 365- 367 ,(1998) , 10.1007/BF01709465

Shyam Sundar, TK Jha, CP Thakur, Juergen Engel, Herbert Sindermann, Christina Fischer, Klaus Junge, Anthony Bryceson, Jonathan Berman, None, Oral Miltefosine for Indian Visceral Leishmaniasis The New England Journal of Medicine. ,vol. 347, pp. 1739- 1746 ,(2002) , 10.1056/NEJMOA021556

Koert Ritmeijer, Abren Dejenie, Yibeltal Assefa, Tadesse Beyene Hundie, Jo Mesure, Gerry Boots, Margriet den Boer, Robert N. Davidson, A Comparison of Miltefosine and Sodium Stibogluconate for Treatment of Visceral Leishmaniasis in an Ethiopian Population with High Prevalence of HIV Infection Clinical Infectious Diseases. ,vol. 43, pp. 357- 364 ,(2006) , 10.1086/505217

Roberto Manfredi, Ginevra Marinacci, Leonardo Calza, Beatrice Passarini, Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration International Journal of Antimicrobial Agents. ,vol. 31, pp. 590- 592 ,(2008) , 10.1016/J.IJANTIMICAG.2008.02.007

A. Dejenie Belay, Y. Asafa, J. Mesure, R. N. Davidson, Successful miltefosine treatment of post-kala-azar dermal leishmaniasis occurring during antiretroviral therapy Annals of Tropical Medicine and Parasitology. ,vol. 100, pp. 223- 227 ,(2006) , 10.1179/136485906X91440

Jesús Troya, Angela Casquero, Elena Refoyo, Manuel L. Fernández-Guerrero, Miguel Górgolas, Long term failure of miltefosine in the treatment of refractory visceral leishmaniasis in AIDS patients Scandinavian Journal of Infectious Diseases. ,vol. 40, pp. 78- 80 ,(2008) , 10.1080/00365540701466215

Nuno Marques, Rosa Sá, Filomena Coelho, Joaquim Oliveira, J. Saraiva Da Cunha, A. Meliço-Silvestre, Miltefosine for visceral leishmaniasis relapse treatment and secondary prophylaxis in HIV-infected patients Scandinavian Journal of Infectious Diseases. ,vol. 40, pp. 523- 526 ,(2008) , 10.1080/00365540701787800